Abiopharma

Innate Pharma Enters Strategic Partnership With Sobi to License Lacutamab in T-cell Lymphoma

FUTU Deadline: FUTU Investors Have Opportunity to Lead Futu Holdings Limited Securities Fraud Lawsuit

ASM announces start of €150 million share buyback program

Innate Pharma conclut un partenariat stratégique avec Sobi pour lacutamab dans les lymphomes T

Innate Pharma Enters Strategic Partnership With Sobi to License Lacutamab in T-cell Lymphoma

Almirall Enters Collaboration With CrystalO for the Discovery and Development of Novel Small Molecules in Medical Dermatology

Register of shareholders, changes and capital status – exercise of employee warrants

DNOW Investors Have Opportunity to Lead DNOW Inc. Securities Lawsuit Filed by The Rosen Law Firm

Change in holdings of interested parties/officers

AB Science annonce aujourd’hui le succès d’augmentations de capital d’un montant brut total de 14,2 millions d’euros